PreView Medical has developed the ClariCore® Biopsy and Mapping Systems, which utilize AI-powered spectroscopy to classify prostate tissue in real-time and create a precise 3D map of tumors. This technology addresses the limitations of traditional biopsy methods by improving cancer detection rates and enabling targeted focal therapy, thereby reducing the need for radical prostatectomies and associated complications.
Funding
Funding not disclosed
Founders
Product
Problem
Traditional prostate biopsy methods often involve random tissue sampling, which can miss a significant number of cancers, leading to inaccurate diagnoses and potentially unnecessary radical prostatectomies. Radical prostatectomies, while effective, carry a high risk of complications such as erectile dysfunction and incontinence. There is a need for more precise and targeted methods for prostate cancer detection and treatment.
Solution
PreView Medical offers the ClariCore Biopsy and Mapping Systems, which utilize AI-powered spectroscopy to improve prostate cancer detection and enable precise, targeted treatment. The ClariCore Biopsy System classifies prostate tissue as benign or suspicious in real-time during a biopsy, using integrated fiber optics to shine light into the tissue and analyzing the returned light with an AI algorithm. This approach aims to increase cancer detection rates compared to standard biopsies. The ClariCore Mapping System creates a precise 3D map of prostate tumors, guiding focal therapy procedures that target cancerous tissue while sparing healthy tissue, potentially reducing the need for radical prostatectomies and their associated complications.
Target Audience
The primary target audience includes urologists and medical professionals involved in prostate cancer diagnosis and treatment, as well as hospitals and cancer centers seeking to improve detection rates and offer less invasive treatment options.
Features
- ClariCore Biopsy System: Real-time tissue classification during biopsy using AI-powered spectroscopy.
- Integrated fiber optics: Shine specific wavelengths of light into the tissue for analysis.
- AI algorithm: Instantaneously analyzes returned light to classify tissue as benign or suspicious.
- ClariCore Mapping System: Creates a precise 3D map of prostate tumors using spectroscopy.
- Guides focal therapy: Enables targeted energy delivery to cancerous tissue while sparing healthy tissue.
- High accuracy: Demonstrated 83% sensitivity, 85% specificity, and 93% negative predictive value in a multi-center study for tissue classification.